The role of the activating receptor NKG2D in autoimmunity

Molecular Immunology

Volumn 47, Issue 1, 2009, Pages 8-11

  Van Belle, Tom L ^a   von Herrath, Matthias G ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Autoreactivity; Celiac disease; Crohn's disease; Danger signals; Lupus; Multiple sclerosis; Rheumatoid arthritis; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; IMMUNOMODULATING AGENT; NATURAL KILLER CELL RECEPTOR NKG2D; NATURAL KILLER CELL RECEPTOR NKG2D ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY REACTION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CELIAC DISEASE; CELL DEATH; CELL STRESS; CELLULAR IMMUNITY; COLITIS; CROHN DISEASE; CYTOTOXICITY; DISEASE COURSE; DISEASE PREDISPOSITION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GLUTEN FREE DIET; HUMAN; HYPERGLYCEMIA; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; IMMUNOSTIMULATION; IMMUNOSURVEILLANCE; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE FUNCTION; MACROPHAGE ACTIVATION; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

AUTOIMMUNITY; HUMANS; IMMUNE SYSTEM DISEASES; KILLER CELLS, NATURAL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; T-LYMPHOCYTES;

EID: 70350400641     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.02.023     Document Type: Review

References (50)

1. Ahmad T., Marshall S.E., Mulcahy-Hawes K., Orchard T., Crawshaw J., Armuzzi A., Neville M., van Heel D., Barnardo M., Welsh K.I., Jewell D.P., and Bunce M. High resolution MIC genotyping: design and application to the investigation of inflammatory bowel disease susceptibility. Tissue Antigens 60 (2002) 164-179
2. Allez M., Tieng V., Nakazawa A., Treton X., Pacault V., Dulphy N., Caillat-Zucman S., Paul P., Gornet J.M., Douay C., Ravet S., Tamouza R., Charron D., Lemann M., Mayer L., and Toubert A. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions. Gastroenterology 132 (2007) 2346-2358
3. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., and Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296 (2002) 1323-1326
4. Atkinson M.A., and Eisenbarth G.S. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358 (2001) 221-229
5. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., and Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285 (1999) 727-729
6. Bhagat G., Naiyer A.J., Shah J.G., Harper J., Jabri B., Wang T.C., Green P.H., and Manavalan J.S. Small intestinal CD8+TCRgammadelta+NKG2A+ intraepithelial lymphocytes have attributes of regulatory cells in patients with celiac disease. J. Clin. Invest. 118 (2008) 281-293
7. Bottino C., Castriconi R., Moretta L., and Moretta A. Cellular ligands of activating NK receptors. Trends Immunol. 26 (2005) 221-226
8. Cerwenka A., and Lanier L.L. NKG2D ligands: unconventional MHC Class I-like molecules exploited by viruses and cancer. Tissue Antigens 61 (2003) 335-343
9. Chan C.W., Crafton E., Fan H.N., Flook J., Yoshimura K., Skarica M., Brockstedt D., Dubensky T.W., Stins M.F., Lanier L.L., Pardoll D.M., and Housseau F. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat. Med. 12 (2006) 207-213
10. Diefenbach A., Tomasello E., Lucas M., Jamieson A.M., Hsia J.K., Vivier E., and Raulet D.H. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat. Immunol. 3 (2002) 1142-1149
11. Eagle R.A., and Trowsdale J. Promiscuity and the single receptor: NKG2D. Nat. Rev. Immunol. 7 (2007) 737-744
12. Fernandez-Morera J.L., Rodriguez-Rodero S., Lahoz C., Tunon A., Astudillo A., Garcia-Suarez O., Martinez-Borra J., Lopez-Vazquez A., Rodrigo L., Gonzalez S., and Lopez-Larrea C. Soluble MHC Class I chain-related protein B serum levels correlate with disease activity in relapsing-remitting multiple sclerosis. Hum. Immunol. 69 (2008) 235-240
13. Fernandez-Morera J.L., Rodriguez-Rodero S., Tunon A., Martinez-Borra J., Vidal-Castineira J.R., Lopez-Vazquez A., Rodrigo L., Rodrigo P., Gonzalez S., Lahoz C.H., and Lopez-Larrea C. Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility. Tissue Antigens 72 (2008) 54-59
14. Fernandez N.C., Treiner E., Vance R.E., Jamieson A.M., Lemieux S., and Raulet D.H. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105 (2005) 4416-4423
15. Galazka G., Jurewicz A., Orlowski W., Stasiolek M., Brosnan C.F., Raine C.S., and Selmaj K. EAE tolerance induction with Hsp70-peptide complexes depends on H60 and NKG2D activity. J. Immunol. 179 (2007) 4503-4512
16. Galazka G., Stasiolek M., Walczak A., Jurewicz A., Zylicz A., Brosnan C.F., Raine C.S., and Selmaj K.W. Brain-derived heat shock protein 70-peptide complexes induce NK cell-dependent tolerance to experimental autoimmune encephalomyelitis. J. Immunol. 176 (2006) 1588-1599
17. Gallucci S., and Matzinger P. Danger signals: SOS to the immune system. Curr. Opin. Immunol. 13 (2001) 114-119
18. Gilfillan S., Ho E.L., Cella M., Yokoyama W.M., and Colonna M. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat. Immunol. 3 (2002) 1150-1155
19. Groh V., Bruhl A., El-Gabalawy H., Nelson J.L., and Spies T. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 100 (2003) 9452-9457
20. Groh V., Smythe K., Dai Z., and Spies T. Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity. Nat. Immunol. 7 (2006) 755-762
21. Groh V., Wu J., Yee C., and Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419 (2002) 734-738
22. Horng T., Bezbradica J.S., and Medzhitov R. NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway. Nat. Immunol. 8 (2007) 1345-1352
23. Hue S., Mention J.J., Monteiro R.C., Zhang S., Cellier C., Schmitz J., Verkarre V., Fodil N., Bahram S., Cerf-Bensussan N., and Caillat-Zucman S. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21 (2004) 367-377
24. Huseby E.S., Liggitt D., Brabb T., Schnabel B., Ohlen C., and Goverman J. A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J. Exp. Med. 194 (2001) 669-676
25. Kim S., Poursine-Laurent J., Truscott S.M., Lybarger L., Song Y.J., Yang L., French A.R., Sunwoo J.B., Lemieux S., Hansen T.H., and Yokoyama W.M. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436 (2005) 709-713
26. Kjellev S., Haase C., Lundsgaard D., Urso B., Tornehave D., and Markholst H. Inhibition of NKG2D receptor function by antibody therapy attenuates transfer-induced colitis in SCID mice. Eur. J. Immunol. 37 (2007) 1397-1406
27. Kukreja A., Cost G., Marker J., Zhang C., Sun Z., Lin-Su K., Ten S., Sanz M., Exley M., Wilson B., Porcelli S., and Maclaren N. Multiple immuno-regulatory defects in type-1 diabetes. J. Clin. Invest. 109 (2002) 131-140
28. Lanier L.L. NK cell recognition. Annu. Rev. Immunol. 23 (2005) 225-274
29. Ly D., Mi Q.S., Hussain S., and Delovitch T.L. Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells. J. Immunol. 177 (2006) 3695-3704
30. Maiuri L., Ciacci C., Ricciardelli I., Vacca L., Raia V., Auricchio S., Picard J., Osman M., Quaratino S., and Londei M. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 362 (2003) 30-37
31. Mandelboim O., Lieberman N., Lev M., Paul L., Arnon T.I., Bushkin Y., Davis D.M., Strominger J.L., Yewdell J.W., and Porgador A. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409 (2001) 1055-1060
32. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12 (1994) 991-1045
33. Matzinger P. An innate sense of danger. Semin. Immunol. 10 (1998) 399-415
34. Mention J.J., Ben Ahmed M., Begue B., Barbe U., Verkarre V., Asnafi V., Colombel J.F., Cugnenc P.H., Ruemmele F.M., McIntyre E., Brousse N., Cellier C., and Cerf-Bensussan N. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 125 (2003) 730-745
35. Meresse B., Chen Z., Ciszewski C., Tretiakova M., Bhagat G., Krausz T.N., Raulet D.H., Lanier L.L., Groh V., Spies T., Ebert E.C., Green P.H., and Jabri B. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21 (2004) 357-366
36. Nikitina-Zake L., Rajalingham R., Rumba I., and Sanjeevi C.B. Killer cell immunoglobulin-like receptor genes in Latvian patients with type 1 diabetes mellitus and healthy controls. Ann. N Y Acad. Sci. 1037 (2004) 161-169
37. Ogasawara K., Hamerman J.A., Ehrlich L.R., Bour-Jordan H., Santamaria P., Bluestone J.A., and Lanier L.L. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 20 (2004) 757-767
38. Ogasawara K., Hamerman J.A., Hsin H., Chikuma S., Bour-Jordan H., Chen T., Pertel T., Carnaud C., Bluestone J.A., and Lanier L.L. Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 18 (2003) 41-51
39. Ogasawara K., and Lanier L.L. NKG2D in NK and T cell-mediated immunity. J. Clin. Immunol. 25 (2005) 534-540
40. Rodacki M., Svoren B., Butty V., Besse W., Laffel L., Benoist C., and Mathis D. Altered natural killer cells in type 1 diabetic patients. Diabetes 56 (2007) 177-185
41. Schepis D., Gunnarsson I., Eloranta M.L., Lampa J., Jacobson S.H., Karre K., and Berg L. Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus. Immunology 126 (2009) 140-146
42. Schrambach S., Ardizzone M., Leymarie V., Sibilia J., and Bahram S. In vivo expression pattern of MICA and MICB and its relevance to auto-immunity and cancer. PLoS ONE 2 (2007) e518
43. Sollid L.M., and Jabri B. Is celiac disease an autoimmune disorder?. Curr. Opin. Immunol. 17 (2005) 595-600
44. Stepniak D., and Koning F. Celiac disease-sandwiched between innate and adaptive immunity. Hum. Immunol. 67 (2006) 460-468
45. Wen L., Ley R.E., Volchkov P.Y., Stranges P.B., Avanesyan L., Stonebraker A.C., Hu C., Wong F.S., Szot G.L., Bluestone J.A., Gordon J.I., and Chervonsky A.V. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455 (2008) 1109-1113
46. Wiemann K., Mittrucker H.W., Feger U., Welte S.A., Yokoyama W.M., Spies T., Rammensee H.G., and Steinle A. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo. J. Immunol. 175 (2005) 720-729
47. Yokoyama W.M., and Kim S. How do natural killer cells find self to achieve tolerance?. Immunity 24 (2006) 249-257
48. Zamvil S., Nelson P., Trotter J., Mitchell D., Knobler R., Fritz R., and Steinman L. T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature 317 (1985) 355-358
49. Zhang B., Yamamura T., Kondo T., Fujiwara M., and Tabira T. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 186 (1997) 1677-1687
50. Zhang C., Zhang J., Niu J., and Tian Z. Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation. Cytokine 42 (2008) 128-136